Alban Gaultier

Alban Gaultier

Auto-generated profile, based on publicly available information

Alban Gaultier


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ALAntoine Louveau
Antoine Louveau
JHJasmin Herz
Jasmin Herz
MAMaria Nordheim Alme
Maria Nordheim Alme
ASAndrea Francesca Salvador
Andrea Francesca Salvador
MDMichael Q. Dong
Michael Q. Dong
JKJonathan Kipnis
Jonathan Kipnis

7 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
IMIoana A. Marin
Ioana A. Marin
JGJennifer E. Goertz
Jennifer E. Goertz
TRTiantian Ren
Tiantian Ren
SRStephen S. Rich
Stephen S. Rich
SOSuna Onengut-Gumuscu
Suna Onengut-Gumuscu
AGAlban Gaultier
Alban Gaultier
Depressive disorders often run in families, which, in addition to the genetic component, may point to the microbiome as a causative agent. Here, we employed a combination of behavioral, molecular and computational techniques to test the role of the microbiota in mediating despair behavior. In chronically stressed mice displaying despair behavior, we found that the microbiota composition and the metabolic signature dramatically change. Specifically, we observed reduced Lactobacillus and increased circulating kynurenine levels as the most prominent changes in stressed mice. Restoring intestinal Lactobacillus levels was sufficient to improve the metabolic alterations and behavioral abnormalities. Mechanistically, we identified that Lactobacillus-derived reactive oxygen species may suppress host kynurenine metabolism, by inhibiting the expression of the metabolizing enzyme, IDO1, in the intestine. Moreover, maintaining elevated kynurenine levels during Lactobacillus supplementation diminished the treatment benefits. Collectively, our data provide a mechanistic scenario for how a microbiota player (Lactobacillus) may contribute to regulating metabolism and resilience during stress.

6 February 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DRDorian A. Rosen
Dorian A. Rosen
SSScott M. Seki
Scott M. Seki
AFAnthony Fernández-Castañeda
Anthony Fernández-Castañeda
RBRebecca M. Beiter
Rebecca M. Beiter
JEJacob ECCLES
Jacob ECCLES
AGAlban Gaultier
Alban Gaultier
Sigma-1 receptor is a critical inhibitor of endoplasmic reticulum–driven inflammation and a potential therapeutic target in septic shock.

1 October 2016 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
AFAnthony Fernandez-Castaneda
Anthony Fernandez-Castaneda
AGAlban Gaultier
Alban Gaultier

25 June 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
GNGeoffrey T. Norris
Geoffrey T. Norris
ISIgor Smirnov
Igor Smirnov
AFAnthony J. Filiano
Anthony J. Filiano
HSHannah M. Shadowen
Hannah M. Shadowen
KCKris R. Cody
Kris R. Cody
JKJonathan Kipnis
Jonathan Kipnis
Phagocytosis of synaptic material by microglia is critical for central nervous system development. Less well understood is this microglial function in the injured adult brain. Assay of microglial phagocytosis is challenging, because peripheral myeloid cells engraft the site of injury, which could obscure interpretation of microglial roles. The model used here, optic nerve crush injury, results in degeneration of synapses in the dorsal lateral geniculate nucleus (dLGN), which stimulates rapid activation and engulfment of synaptic material by resident microglia without myeloid cell engraftment. Pharmacological depletion of microglia causes postinjury accumulation of synaptic debris, suggesting that microglia are the dominant postinjury phagocytes. Genetic or pharmacological manipulations revealed that neuronal activity does not trigger microglia phagocytosis after injury. RNA sequencing reveals C1q and CD11b/CR3 involvement in clearance of debris by dLGN-resident microglia. Indeed, C1qa−/− and Itgam−/− mice exhibit impaired postinjury debris clearance. Our results show how neurodegenerative debris is cleared by microglia and offers a model for studying its mechanisms and physiological roles.

11 July 2016 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
TCTzu-Ying Chuang
Tzu-Ying Chuang
YGYong Guo
Yong Guo
SSScott M. Seki
Scott M. Seki
ARAbagail M. Rosen
Abagail M. Rosen
DJDavid M. Johanson
David M. Johanson
AGAlban Gaultier
Alban Gaultier
Multiple sclerosis is a devastating neurological disorder characterized by the autoimmune destruction of the central nervous system myelin. While T cells are known orchestrators of the immune response leading to MS pathology, the precise contribution of CNS resident and peripheral infiltrating myeloid cells is less well described. Here, we explore the myeloid cell function of Low-density lipoprotein receptor-related protein-1 (LRP1), a scavenger receptor involved in myelin clearance and the inflammatory response, in the context of Multiple sclerosis. Supporting its central role in Multiple sclerosis pathology, we find that LRP1 expression is increased in Multiple sclerosis lesions in comparison to the surrounding healthy tissue. Using two genetic mouse models, we show that deletion of LRP1 in microglia, but not in peripheral macrophages, negatively impacts the progression of experimental autoimmune encephalomyelitis, an animal model of Multiple sclerosis. We further show that the increased disease severity in experimental autoimmune encephalomyelitis is not due to haplodeficiency of the Cx3cr1 locus. At the cellular level, microglia lacking LRP1 adopt a pro-inflammatory phenotype characterized by amoeboid morphology and increased production of the inflammatory mediator TNF-α. We also show that LRP1 functions as a robust inhibitor of NF-kB activation in myeloid cells via a MyD88 dependent pathway, potentially explaining the increase in disease severity observed in mice lacking LRP1 expression in microglia. Taken together, our data suggest that the function of LRP1 in microglia is to keep these cells in an anti-inflammatory and neuroprotective status during inflammatory insult, including experimental autoimmune encephalomyelitis and potentially in Multiple sclerosis.